# Genetic predisposition to coffee consumption and the association with the early risk of atherosclerosis

**Authors:** Xiangyu Qiao, Vanessa William Toma, Jing Wang, Ángel Herraiz-Adillo, Simon Söderholm, Daniel Berglind, Susanna Calling, Bledar Daka, Mats Martinell, Frida Bergman, Pontus Henriksson, Bijar Ghafouri, Martin Ulander, Carl Johan Östgren, Claudio Cantù, Wen Zhong, Fredrik Iredahl

PMC · DOI: 10.1038/s41598-026-44122-2 · 2026-03-22

## TL;DR

This study explores how genetic factors related to coffee consumption might influence early signs of heart disease, finding possible links in frequent coffee drinkers.

## Contribution

The study uses genetic and multi-omics approaches to explore how coffee consumption may influence early atherosclerosis risk in frequent consumers.

## Key findings

- Genetic predisposition to higher coffee consumption is linked to increased coronary atherosclerosis risk in frequent drinkers.
- Two SNPs in AHR and CYP1A1/CYP1A2 are associated with atherosclerosis in high coffee consumers.
- Lipid and inflammation-related biomarkers correlate with genetically influenced coffee consumption.

## Abstract

The cardiovascular effects of coffee consumption remain debated, particularly regarding early-stage subclinical atherosclerosis. This study investigated the association between coffee intake, genetic predisposition, and the risk of subclinical coronary and carotid atherosclerosis in 24,835 participants from the Swedish CArdioPulmonary bioImage Study (SCAPIS). Coffee intake was assessed via self-reported questionnaires. Atherosclerosis was assessed via segment involvement score (SIS), coronary artery calcium score (CACS) and carotid plaque. Observational analysis showed no significant association between coffee consumption and SIS, CACS, or carotid plaques. However, both one-sample and two-sample (SCAPIS and UK Biobank) Mendelian randomization (MR) analyses showed an association between genetic predisposition to higher coffee consumption and increased SIS. Stratification analyses further explored differences in genetic associations across varying coffee consumption levels. Among individuals consuming coffee more than twice daily, two coffee consumption-associated single nucleotide polymorphisms (SNPs) in AHR and CYP1A1/CYP1A2 were correlated with SIS. Integrative metabolomics and proteomics analyses identified lipid-related metabolites (triglycerides, phospholipids, free cholesterol) and inflammation-related proteins (DLK1, IL1RL2, CCL17) associated with the genetic proxy of coffee consumption. These findings suggest that genetically influenced coffee consumption may be associated with coronary atherosclerosis risk in frequent coffee drinkers, although the underlying biological basis remains to be clarified.

The online version contains supplementary material available at 10.1038/s41598-026-44122-2.

## Linked entities

- **Genes:** AHR (aryl hydrocarbon receptor) [NCBI Gene 196], CYP1A1 (cytochrome P450 family 1 subfamily A member 1) [NCBI Gene 1543], CYP1A2 (cytochrome P450 family 1 subfamily A member 2) [NCBI Gene 1544]
- **Proteins:** DLK1 (delta like non-canonical Notch ligand 1), IL1RL2 (interleukin 1 receptor like 2), CCL17 (C-C motif chemokine ligand 17)
- **Diseases:** atherosclerosis (MONDO:0005311)

## Full-text entities

- **Genes:** IL1RL2 (interleukin 1 receptor like 2) [NCBI Gene 8808] {aka IL-1Rrp2, IL-36R, IL1R-rp2, IL1RRP2}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, CYP1A1 (cytochrome P450 family 1 subfamily A member 1) [NCBI Gene 1543] {aka AHH, CP11, CYP1, CYPIA1, P1-450, P450-C}, APOA1 (apolipoprotein A1) [NCBI Gene 335] {aka AMYLD3, HPALP2, apo(a)}, DLK1 (delta like non-canonical Notch ligand 1) [NCBI Gene 8788] {aka DLK, DLK-1, Delta1, FA1, PREF1, Pref-1}, PRSS27 (serine protease 27) [NCBI Gene 83886] {aka CAPH2, MPN}, APOB (apolipoprotein B) [NCBI Gene 338] {aka FCHL2, FLDB, LDLCQ4, apoB-100, apoB-48}, AHR (aryl hydrocarbon receptor) [NCBI Gene 196] {aka FVH3, RP85, bHLHe76}, CCL17 (C-C motif chemokine ligand 17) [NCBI Gene 6361] {aka A-152E5.3, ABCD-2, SCYA17, TARC}, CYP1A2 (cytochrome P450 family 1 subfamily A member 2) [NCBI Gene 1544] {aka CP12, CYPIA2, P3-450, P450(PA)}, FAS (Fas cell surface death receptor) [NCBI Gene 355] {aka ALPS1A, APO-1, APT1, CD95, FAS1, FASTM}
- **Diseases:** CACS (MESH:D003324), inflammation (MESH:D007249), SCAPIS (MESH:D006323), GRS (MESH:D030342), atherosclerotic plaques (MESH:D058226), Atherosclerosis (MESH:D050197), carotid plaque (MESH:D016893), sex chromosome aneuploidies (MESH:D025064), artery calcium (MESH:D002128), CVD (MESH:D002318), stenosis (MESH:D003251), T2D (MESH:D003924), obesity (MESH:D009765), SIS (MESH:C537538), heart disease (MESH:D006331), Computed (MESH:C000719218), coronary and carotid atherosclerosis (MESH:D002340), coronary stenosis (MESH:D023921), MR (MESH:C562757), vascular dysfunction (MESH:D002561), MI (MESH:D009203), stroke (MESH:D020521)
- **Chemicals:** glucose (MESH:D005947), lipid (MESH:D008055), EDTA (MESH:D004492), LA (MESH:D007811), TG (MESH:D014280), Omega-6 fatty acid (MESH:D043371), alcohol (MESH:D000438), phospholipids (MESH:D010743), fatty acid (MESH:D005227), Lpa (MESH:D010649), cholesterol (MESH:D002784), Linoleic acid (MESH:D019787), CCTA (-), MUFA (MESH:D005229), nitroglycerin (MESH:D005996), Caffeine (MESH:D002110), calcium (MESH:D002118)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Mutations:** rs2763981, rs4410790, rs2472297

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13009213/full.md

---
Source: https://tomesphere.com/paper/PMC13009213